Cancer prevalence set to treble
(Medical Xpress) -- The number of older people (aged 65 and over) living with cancer in the UK is set to more than treble by 2040 from 1.3 million in 2010 to 4.1 million according to a new study by Kings College London researchers.
The Macmillan-funded study, published in The British Journal of Cancer, shows nearly one in four (23 per cent) older people will have had a cancer diagnosis in 2040 almost double the proportion in 2010 (13 per cent). This is nearly four times the proportion for people aged 45-64.
Lung cancer prevalence in older women will see the biggest increase. The prevalence of lung cancer in older women will more than double from in 2010 to 2040 (from 319 to 831 per 100, 000), whereas lung cancer prevalence in older men is expected to decrease. This is due to a dramatic decline in smoking among men in England since the 1970s.
The sharp rise in cancer prevalence is likely to be due to a number of reasons including the ageing population, increasing incidence and increasing cancer survival.
Professor Henrik Møller, one of the study authors at Kings, says: The aim of this research is to provide long term projections of cancer prevalence in the UK. The research shows that large increases can be expected in the oldest age groups in the coming decades and with this an increased demand upon health services.
Currently older cancer patients face a multitude of barriers to getting the best care and treatment. These include under treatment, a lack of practical support at home preventing them from going to hospital to get treatment and poor management of non-cancer related health problems.
Ciarán Devane, Chief Executive at Macmillan Cancer Support, said: The care of older cancer patients is the ticking time bomb for society. These stark predictions should act as a warning to the NHS and social care providers of the problems ahead if older cancer patients are not offered the best treatment and support.
We have a moral duty to give people the best chance of beating cancer, regardless of their age. For cancer survival to improve, older people must be given the right treatment at the correct level of intensity, together with the practical support to enable them to take it up.
The barriers to older people getting treatment must be tackled. If we dont get this right now many older people will be dying unnecessarily from cancer in the future.
Macmillan is calling for a more effective way of assessing older people for treatment, more short-term practical support to enable them to take up recommended treatment and training for professionals working with older people within the NHS to promote age equality.
Macmillan, in partnership with Age UK and the Department of Health, has set up five pilots to test new models of older peoples care. They will report in December 2012.
More information: Maddams J, Utley M and Møller H. 2012. 'Projections of cancer prevalence in the United Kingdom, 20102040'. British Journal of Cancer. www.nature.com/bjc… 012366a.html
Journal reference: British Journal of Cancer
Provided by King's College London
- Age affects risk of being diagnosed with cancer at advanced stage Mar 02, 2012 | not rated yet | 0
- Elderly breast cancer patients less likely to get surgery Jun 17, 2011 | not rated yet | 0
- Almost half of cancer survivors have ill health in later years Oct 11, 2011 | not rated yet | 0
- Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDA Jul 06, 2011 | not rated yet | 0
- Report estimates nearly 18 million cancer survivors in US by 2022 Jun 14, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer 11 hours ago | not rated yet | 0
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer 11 hours ago | not rated yet | 1
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer May 18, 2013 | 5 / 5 (2) | 0
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer May 17, 2013 | not rated yet | 0
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer May 17, 2013 | not rated yet | 0 |
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
3 minutes ago | not rated yet | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
3 minutes ago | not rated yet | 0 |
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
2 hours ago | not rated yet | 0
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
3 hours ago | not rated yet | 0
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
11 hours ago | not rated yet | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
11 hours ago | 4.7 / 5 (3) | 0 |